1. |
Delgado-Escueta AV, Janz D. Consensus guidelines preconception counseling, management, and care of the pregnant woman with epilepsy. Neurology, 1992, 42(4 Suppl 5): 149-160.
|
2. |
Lindhout D, Höppener RJ, Meinardi H. Teratogenicity of antiepileptic drug combinations with special emphasis on epoxidation of carbamazepine. Epilepsia, 1984, 25(1): 77-83.
|
3. |
Scolnik D, Nulman I, Rovet J, et al. Neurodevelopment of children exposed in utero to phenytoin and carbamazepine monotherapy. JAMA, 1994, 271(10): 767-770.
|
4. |
Morrow J, Russell A, Guthrie E, et al. Malformation risks of antiepileptic drugs in pregnancy: a prospective study from the UK Epilepsy and Pregnancy Register. J Neurol Neurosurg Psychiatry, 2006, 77(2): 193-198.
|
5. |
Campbell E, Kennedy F, Russell A, et al. Malformation risks of antiepileptic drug monotherapies in pregnancy: updated results from the UK and Ireland Epilepsy and Pregnancy Registers. J Neurol Neurosurg Psychiatry, 2014, 85(1): 1029-1034.
|
6. |
Hernandez-Diaz S, Smith CR, Shen A, et al. Comparative safety of antiepileptic drugs during pregnancy. Neurology, 2012, 78(2): 1692-1699.
|
7. |
Tomson T, Battino D, Bonizzoni E, et al. EURAP: an international registry of antiepileptic drugs and pregnancy. Epilepsia, 2004, 45(11): 1463-1464.
|
8. |
King PB, Lie RT, Irgens LM, et al. Spina bifida and cleft lip among newborns of Norwegian women with epilepsy: changes related to the use of anticonvulsants. Am J Public Health, 1996, 86(10): 1454-1456.
|
9. |
Kilic D, Pedersen H, Kjaersgaard MI, et al. Birth outcomes after prenatal exposure to antiepileptic drugs-a population-based study. Epilepsia, 2014, 55(7): 1714-1721.
|
10. |
Vajda FJ, O'Brien TJ, Lander CM, et al. The teratogenicity of the newer antiepileptic drugs - an update. Acta Neurol Scand, 2014, 130(4): 234-238.
|
11. |
Cunnington MC, Weil JG, Messenheimer JA, et al. Final results from 18 years of the International Lamotrigine Pregnancy Registry. Neurology, 2011, 76(21): 1817-1823.
|
12. |
Thomas SV, Indrani L, Devi GC, et al. Pregnancy in women with epilepsy preliminary results of kerala registry of epilepsy and pregnancy. Neurol India, 2001, 49(1): 60-66.
|
13. |
Tomson T, Battino D, Bonizzoni E, et al. Dose-dependent risk of malformations with antiepileptic drugs: an analysis of data from the EURAP epilepsy and pregnancy registry. The Lancet Neurology, 2011, 10(2): 609-617.
|
14. |
Jentink J, Loane MA, Dolk H, et al. Valproic acid monotherapy in pregnancy and major congenital malformations. N Engl J Med, 2010, 362(23): 2185-2193.
|
15. |
Hunt S, Russell A, Smithson WH, et al. Topiramate in pregnancy: preliminary experience from the UK Epilepsy and Pregnancy Register. Neurology, 2008, 71(4): 272-276.
|
16. |
Mawhinney E, Craig J, Morrow J, et al. Levetiracetam in pregnancy: results from the UK and Ireland Epilepsy and Pregnancy Registers. Neurology, 2013, 80(4): 400-405.
|
17. |
Holmes LB, Mittendorf R, Shen A, et al. Fetal effects of anticonvulsant polytherapies: different risks from different drug combinations. Arch Neurol, 2011, 68(2): 1275-1281.
|
18. |
ChristiansonA, Howson CP, Modell B. Global report on birth defects [EB/OL]. http://www.marchofdimes.com/globalreport1.
|
19. |
Tomson T, Battino D. Teratogenic effects of antiepileptic drugs. The Lancet Neurology, 2012, 11(4): 803-813.
|
20. |
Campbell E, Devenney E, Morrow J, et al. Recurrence risk of congenital malformations in infants exposed to antiepileptic drugs in utero. Epilepsia, 2013, 54(9): 165-171.
|
21. |
Vajda FJ, O'Brien TJ, Lander CM, et al. Teratogenesis in repeated pregnancies in antiepileptic drug-treated women. Epilepsia, 2013, 54(5): 181-186.
|
22. |
Meador KJ, Baker GA, Browning N, et al. Fetal antiepileptic drug exposure and cognitive outcomes at age 6 years (NEAD study): a prospective observational study. The Lancet Neurology, 2013, 12(7): 244-252.
|
23. |
Baker GA, Bromley RL, Briggs M, et al. IQ at 6 years after in utero exposure to antiepileptic drugs a controlled cohort study. Neurology, 2015, 84(4): 382-390.
|
24. |
Meador KJ, Baker GA, Browning N, et al. Breastfeeding in children of women taking antiepileptic drugs: cognitive outcomes at age 6 years. JAMA Pediatr, 2014, 168(5): 729-736.
|
25. |
Christensen J, Grønborg TK. Prenatal valproate exposure and risk of autism spectrum disorders and childhood autism . JAMA, 2013, 309(16): 1696-1703.
|
26. |
Viale L, Allotey J, Cheong-See F, et al. Epilepsy in pregnancy and reproductive outcomes: a systematic review and meta-analysis. The Lancet, 2015, 386(10006): 1845-1852.
|